Maria Mastri Scrivens
About Maria Mastri Scrivens
Maria Mastri Scrivens serves as the Director of Technology Development at Vaccinex in Rochester, New York, where she has worked since 2019. She has a strong background in project management and client engagement within the biotechnology sector.
Work at Vaccinex
Maria Mastri Scrivens has served as the Director of Technology Development at Vaccinex since 2019. In this role, she is responsible for overseeing technology development projects within the organization. Her work focuses on advancing the company's initiatives in biotechnology, contributing to the overall mission of Vaccinex in the field of therapeutic development. Based in Rochester, New York, she has been instrumental in leading efforts that enhance client engagement and project management within the company.
Education and Expertise
Maria Mastri Scrivens earned her Bachelor of Arts (B.A.) degree in Biology/Biochemistry from Cornell University, where she studied from 1994 to 1998. This academic background provides her with a solid foundation in the biological sciences, which is essential for her work in biotechnology. Her expertise encompasses project management and technology development, particularly in the context of client engagement within the biotechnology sector.
Background
Before her current position at Vaccinex, Maria Mastri Scrivens accumulated valuable experience in the biotechnology field. She worked as an Assay Development Technologist (Scientist II) at Johnson & Johnson, Ortho-Clinical Diagnostics for nine months in 2002-2003. Prior to that, she was a Laboratory Technician IV at the University of Rochester's Philip J. Fay Lab from 1998 to 2001. These roles contributed to her extensive knowledge and skills in technology development and project management.
Achievements
Maria Mastri Scrivens has been involved in various research activities that contribute to advancements in biotechnology. Her work has focused on developing technologies that support the goals of her organization and the broader biotechnology community. Through her roles, she has demonstrated a commitment to enhancing client engagement and driving project success in the biotechnology sector.